(Q36417730)

14 August 2017

1 reference

title

Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes (English)

1 reference

14 August 2017

Calò LA

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

69

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

963-966

1 reference

The role of angiotensin II in regulating vascular structural and functional changes in hypertension

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Inositol trisphosphate and calcium signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Signaling mechanisms underlying the vascular myogenic response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

The L-arginine-nitric oxide pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Role of nitric oxide and its intracellular signalling pathways in the control of Ca2+ homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Control of vascular tone in the syndromes of Bartter and Gitelman

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Bartter's and Gitelman's syndromes: from gene to clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Bartter's/Gitelman's syndrome: a model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Specificity of G(q) and G(11) Protein Signaling in Vascular Myocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Angiotensin II receptors negatively coupled to adenylate cyclase in rat aorta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Angiotensin II receptors negatively coupled to adenylate cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Reduced content of alpha subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Intracellular calcium signalling and vascular reactivity in Bartter's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Increased urinary NO2-/NO3- and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

The heme oxygenase system: a regulator of second messenger gases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

The role of Rho in G protein-coupled receptor signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Increaseed expression of mRNA for regulator of G protein signaling domain-containing Rho guanine nucleotide exchange factors in aorta from stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Emerging roles for RGS proteins in cell signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

A defect in platelet aggregation in Bartter's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Oxidative stress and cardiovascular injury: Part II: animal and human studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

NAD(P)H oxidase: role in cardiovascular biology and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Reactive oxygen species as mediators of signal transduction in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Gene regulation of heme oxygenase-1 as a therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000253

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000253

1 reference

Dimensions Publication ID

14 August 2017

1038499603

0 references

1 reference